A series of video interviews with Dutch key opinion leaders on the latest scientific insights and clinical data surrounding diagnostic and treatment of hematological diseases, such as CML, AML, ITP, myelofibrosis.
Client
Novartis Pharma Netherlands BV
Indication
CML, AML, MF, ITP
Target audience
Hematologists, hemato-oncologists and hematology students.
Goal
Providing education and the latest scientific information with a clinical point a view.
Result
The video-interviews are published on the Hematalks platform, operated by Novartis Pharma Netherlands, and new videos are added monthly. The website is often visited and appreciated by the target audience.